Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans

AIDS. 1996 Dec;10(14):1745-7. doi: 10.1097/00002030-199612000-00027.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections
  • Administration, Oral
  • Amphotericin B / administration & dosage*
  • Amphotericin B / pharmacology
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / pharmacology
  • Candidiasis / drug therapy*
  • Candidiasis / etiology
  • Drug Resistance, Microbial
  • HIV Infections / complications*
  • HIV-1*
  • Humans
  • Mouth / microbiology

Substances

  • Antifungal Agents
  • Amphotericin B